All News
Filter News
Found 808,674 articles
-
Fuse Medical Reports First Quarter 2019 Results
5/8/2019
Fuse Medical, Inc., announced that it has filed its quarterly report on Form 10-Q for the first quarter ended March 31, 2019, with the United States Securities and Exchange Commission, on Tuesday, May 7, 2019.
-
GBT Reports Recent Business Progress and First Quarter 2019 Financial Results
5/8/2019
Global Blood Therapeutics today reported recent business progress and financial results for the first quarter ended March 31, 2019.
-
Regen BioPharma, Inc. Responds to Fake News Release
5/8/2019
Regen BioPharma, Inc. has received a number of inquiries regarding a potential reverse merger with another biotechnology related company.
-
Danaher to Present at Bank of America Merrill Lynch Health Care Conference
5/8/2019
Danaher Corporation announced that Executive Vice President and Chief Financial Officer, Matt McGrew, and Executive Vice President, Rainer Blair, will be presenting at the Bank of America Merrill Lynch Health Care Conference in Las Vegas, Nevada on Wednesday, May 15, 2019 at 8:00 a.m. PT.
-
Rho CEO Laura Helms-Reece Named CEO of the Year by Triangle Business Journal
5/8/2019
Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, announced today that Laura Helms Reece, DrPH and co-CEO of the company, was named a CEO of the Year by the Triangle Business Journal.
-
AIVITA Biomedical to Present at Aesthetics and Regenerative Medicine Conferences in May
5/8/2019
AIVITA Biomedical announced that it will be exhibiting at two upcoming conferences in May for skincare and regenerative medicine.
-
Carestream Releases ImageView Software for DRX-Revolution Mobile X-ray System
5/8/2019
New software offers advanced features, enhanced workflow and improved security
-
Xencor to Present at Upcoming Investor Conferences - May 8, 2019
5/8/2019
Xencor, Inc. announced that company management will present at two upcoming conferences
-
SCYNEXIS Reports First Quarter 2019 Financial Results and Provides Company Update
5/8/2019
Continued advancement of VVC program, including completed favorable embryo-fetal safety profile, further supports a potential first NDA submission of oral ibrexafungerp in the second half of 2020
-
CryoConcepts Receives FDA Clearance on Two Cryosurgical Devices for the Physician Office Market
5/8/2019
CryoConcepts, LP, a market leader in the development and manufacture of cryosurgical products, announced today they have received FDA clearance on two new, patent pending, cryosurgical devices for the physician's office market.
-
Apyx Medical Corporation Reports First Quarter 2019 Financial Results and Updates Fiscal Year 2019 Outlook
5/8/2019
Advanced Energy Sales of $4.4 million in Q1, up 66% year-over-year
-
Elaine Chambers Joins CDC Foundation Board of Directors
5/8/2019
Philanthropist Elaine Chambers has been elected to the board of directors of the CDC Foundation. Chambers has a passion for supporting educational and health initiatives both in Northern California, where she resides, as well as nationally.
-
Proteostasis Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
5/8/2019
Proteostasis is a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis and other diseases caused by dysfunctional protein processing
-
CONCEPT Professional Training at Palo Alto University Announces Summer Training Institute Focusing on Clinical and Forensic Mental Health
5/8/2019
CONCEPT Professional Training at Palo Alto University, a global leader in online professional training in forensic mental health, is hosting its Summer Training Institute 2019 at Palo Alto University, June 17 to 21.
-
Biostage to Host Conference Call to Discuss First Quarter 2019 Financial Results and Business Update
5/8/2019
Conference Call with Live Audio Webcast on Tuesday May 14th at 9:00 AM ET
-
Semma Therapeutics Announces Publication in Nature Demonstrating Advancements in Regenerative Cell Therapy for Type 1 Diabetes
5/8/2019
Semma Therapeutics, Inc., a biotechnology company pioneering the curative use of stem cells in regenerative medicine, today announced the journal Nature published data demonstrating improvements in the production of beta cells (cells that produce insulin) from stem cells
-
BELLUS Health Provides Update on Its Chronic Cough Drug Candidate BLU-5937 and Reports Financial and Operating Results for the First Quarter Ended March 31, 2019
5/8/2019
Two abstracts, including data from the clinical Phase 1 study for BLU-5937, were accepted for presentation at the American Thoracic Society Conference on May 21 and at the American Cough Conference on June 7
-
Kalderos Secures $7 Million Funding to Deliver Data-backed, Financially Transparent Drug Discount Management Solution
5/8/2019
Kalderos today announced $7 million in funding to accelerate market adoption of its first-to-market platform that delivers unparalleled visibility into prescription drug discount compliance.
-
Hanger Announces Financial Results for the First Quarter of 2019
5/8/2019
Net revenue was $236.4 million for the three months ended March 31, 2019, compared to $234.0 million for the same period in 2018, reflecting a net revenue increase of 1.0 percent year-over-year.
-
Make-A-Wish® Receives Donation from Bristol-Myers Squibb to Grant Life-Changing Wishes for Third Consecutive Year
5/8/2019
Since 2017, Make-A-Wish® America has received more than $3 million in charitable donations from Bristol-Myers Squibb Company, including a $500,000 contribution this year, with the purpose of granting more life-changing wishes for children with cancer.